Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients

References

• Yamashita Y-I, Hayashi H, Imai K, et al. Perioperative allogeneic blood transfusion does not influence patient survival after hepatectomy for hepatocellular carcinoma: a propensity score matching analysis. World J Surgery. 2019;43(11):2894–2901.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Vibert E, Schwartz M, Olthoff KM. Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol. 2020;72(2):262–276. doi:10.1016/j.jhep.2019.11.017
   PubMed Web of Science ®Google Scholar
• Kim JH. Pure laparoscopic right hepatectomy using modified liver hanging maneuver: technical evolution from caudal approach toward ventral approach. J Gastrointestinal Surg. 2018;22(8):1343–1349. doi:10.1007/s11605-018-3736-7
   PubMed Web of Science ®Google Scholar
• Nanashima A, Ariizumi S-I, Yamamoto M. Right anatomical hepatectomy: pioneers, evolution, and the future. Surgery Today. 2020;50(2):97–105. doi:10.1007/s00595-019-01809-6
   PubMed Web of Science ®Google Scholar
• Cescon M, Vetrone G, Grazi GL, et al. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009;249(6):995–1002. doi:10.1097/SLA.0b013e3181a63c74
   PubMed Web of Science ®Google Scholar
• Wada H, Eguchi H, Nagano H, et al. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surgery Today. 2018;48(1):73–79. doi:10.1007/s00595-017-1553-3
   PubMed Web of Science ®Google Scholar
• Kuroda S, Tashiro H, Kobayashi T, Oshita A, Amano H, Ohdan H. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World j Surgery. 2012;36(3):651–658. doi:10.1007/s00268-012-1425-3
   PubMed Web of Science ®Google Scholar
• Yang T, Lu J-H, Lau WY, et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: a Propensity Score Matching Analysis. J Hepatol. 2016;64(3):583–593. doi:10.1016/j.jhep.2015.10.012
   PubMed Web of Science ®Google Scholar
• Xu L-N, Xu -Y-Y, Gao D-W. Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy. J Huazhong Univ Sci Tech. 2016;36(4):523–528. doi:10.1007/s11596-016-1619-2
   Google Scholar
• Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K. The association between transfusion and cancer‐free survival after curative resection for hepatocellular carcinoma. Cancer. 1993;72(6):1866–1871. doi:10.1002/1097-0142(19930915)72:6<1866::AID-CNCR2820720613>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Sugita S, Sasaki A, Iwaki K, et al. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intra-operative allogenic blood transfusion: a retrospective study. Eur J Surgical Oncol. 2008;34(3):339–345. doi:10.1016/j.ejso.2007.02.010
   PubMed Web of Science ®Google Scholar
• Harada N, Shirabe K, Maeda T, Kayashima H, Ishida T, Maehara Y. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child–Pugh class A patients. World j Surgery. 2015;39(4):1044–1051. doi:10.1007/s00268-014-2891-6
   PubMed Web of Science ®Google Scholar
• Peng T, Zhao G, Wang L, et al. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis. Clin Transl Oncol. 2018;20(6):719–728. doi:10.1007/s12094-017-1773-4
   PubMed Web of Science ®Google Scholar
• Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bul. 2004;70(1):15–28.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Takeda S, Fujii T, Sugimoto H, Nomoto S, Nakao A. Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surgical Oncol. 2011;104(7):814–821. doi:10.1002/jso.21977
   PubMed Web of Science ®Google Scholar
• Elwood NR, Martin AN, Turrentine FE, Jones RS, Zaydfudim VM. The negative effect of perioperative red blood cell transfusion on morbidity and mortality after major abdominal operations. Am J Surg. 2018;216(3):487–491. doi:10.1016/j.amjsurg.2018.02.015
   PubMed Web of Science ®Google Scholar
• Xun Y, Tian H, Hu L, Yan P, Yang K, Guo T. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: a systematic review and meta-analysis of cohort studies. Medicine. 2018;97(43):e12911. doi:10.1097/MD.0000000000012911
   PubMed Web of Science ®Google Scholar
• Chen G-X, C-Y Q, W-J H, et al. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma. BMC Cancer. 2020;20(1):1–12. doi:10.1186/s12885-020-06980-5
   Web of Science ®Google Scholar
• Xia F, Zhang Q, Huang Z, et al. Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: a Propensity Score Matching Analysis. Front Surgery. 2022;9.
   Web of Science ®Google Scholar
• Peng T, Wang L, Cui H, et al. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma. Eur J Surg Oncol. 2021;47(3):620–627. doi:10.1016/j.ejso.2020.09.021
   PubMed Web of Science ®Google Scholar
• Ishii T, Hatano E, Yasuchika K, Taura K, Seo S, Uemoto S. High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter. Surgery Today. 2014;44(10):1900–1905. doi:10.1007/s00595-013-0792-1
   PubMed Web of Science ®Google Scholar
• Cata J, Wang H, Gottumukkala V, Reuben J, Sessler D. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701. doi:10.1093/bja/aet068
   PubMed Web of Science ®Google Scholar
• Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer. 2001;91(4):771–778. doi:10.1002/1097-0142(20010215)91:4<771::AID-CNCR1063>3.0.CO;2-9
   PubMed Web of Science ®Google Scholar
• Torrance HD, Brohi K, Pearse RM, et al. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann Surg. 2015;261(4):751–759. doi:10.1097/SLA.0000000000000653
   PubMed Web of Science ®Google Scholar
• Patel H, Nasir F, Nash G, Scully M, Kakkar A. Enhanced angiogenesis following allogeneic blood transfusion 1. Clin Lab Haematol. 2004;26(2):129–135. doi:10.1111/j.1365-2257.2004.00589.x
   PubMedGoogle Scholar